Vascular and anti-oxidant actions of flavonols and flavones
However, because these drugs dramatically suppress appetite, total calorie intake often drops quickly
Retatrutide is currently in Phase 3 clinical trials as of March 2026
Conclusions To summarize, the 68-week treatment with coadministered cagrilintide and semaglutide resulted in substantial and clinically meaningful weight loss in adults with overweight or obesity, significantly outperforming monotherapies and placebo (- 5.5% vs
High-fibre complex carbohydrates: Whole grains like quinoa and brown rice, sweet potato, white potatoes, pumpkin, legumes like lentils, chickpeas, beans, and butternut squash